Published in Lab Business Week, November 11th, 2007
Dr. Shearman is currently President and Chief Executive Officer of Neuro-Hitech, Inc. (www.neurohitech.com) (NASDAQ:NHPI), a public biopharmaceutical company focused on developing innovative new drugs for the treatment of neurodegenerative diseases. He is also Chairman of the board of directors of Nereus Pharmaceuticals, Inc. (www.nereuspharm.com), a privately held biotechnology company. From 2001 - 2007, Dr. Shearman...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.